Dr. Priya Sekar, MD

Media Releases

Johns Hopkins Pediatric Cardiologist Leads the Way in Fetal and Pediatric Heart Care

Dr. Priya Sekar, MD, a distinguished pediatric cardiologist, continues to make significant strides in the field of pediatric and fetal cardiology. With over two decades of experience, Dr. Sekar is renowned for her expertise in fetal echocardiography and her commitment to advancing care for children with complex congenital heart conditions. She currently practices at Johns Hopkins Children’s Center and is affiliated with Luminis Health Anne Arundel Medical Center. 

Dr. Sekar’s academic journey began at the Chicago Medical School at Rosalind Franklin University, where she earned her medical degree in 2002. She completed her pediatric residency at Children’s Hospital Oakland, followed by a fellowship in pediatric cardiology at Cincinnati Children’s Hospital Medical Center. Her board certifications in both general pediatrics and pediatric cardiology underscore her comprehensive expertise in the field.  

Beyond her clinical practice, Dr. Sekar contributes to cutting-edge research. She serves as a Clinical Research Physician in the Late Phase Cardiovascular, Renal, and Metabolism (CVRM) group at AstraZeneca, focusing on late-phase clinical trials. Notably, she is the principal investigator for the STOP BLOQ trial, a Phase 3 study aimed at preventing fetal atrioventricular block.  

Dr. Sekar’s research has led to numerous publications in esteemed medical journals. Her work encompasses a range of topics, including the impact of prenatal head growth on hypoplastic left heart syndrome and the role of fetal echocardiography in early detection of congenital heart defects. Her contributions have been instrumental in shaping the current understanding and management of pediatric cardiac conditions. 

Fluent in English, Spanish, and Tamil, Dr. Sekar is dedicated to providing culturally competent care to a diverse patient population. Her practice locations include Johns Hopkins Children’s Center in Baltimore and Luminis Health Maternal and Fetal Medicine in Annapolis, Maryland. Dr. Sekar is currently accepting new patients and continues to be a leading figure in pediatric cardiology.  

Recommended Articles

• Congenital Heart Defects

  Surgical treatment is the most appropriate option for inborn heart defects, which is not something you can put off.What is a congenital heart defect (CHD)?It is combined damage of the heart muscle in which there are structural deformations and anomalies in the inner chamber partitions, as well as...

• What Is Progeria?

  Progeria or Hutchinson-Gilford progeria syndrome (HGPS), is a rare genetic condition characterized by a rapidly aging appearance in children. Newborns and infants born with this condition typically look healthy and normal, but may physically display characteristic facial features, such as prominent...

• Newborn Diagnosis: Tetralogy of Fallot

  Tetralogy of FallotTetralogy of Fallot is a congenital heart defect, which affects the heart’s structure, causing blood with low levels of oxygen to circulate throughout the body. Babies born with tetralogy of Fallot tend to have a blue discoloration of the skin due to low oxygen levels in their...

• What is Kawasaki Disease?

  Kawasaki disease is a rare childhood disease that causes inflammation of the arteries in the body. The characteristic symptoms of the disease, which is high fever and peeling skin, remains for almost a week. In most cases, it gets back to normal without any major issues. Children will be monitored...

• What Is Neonatal Lupus?

  Neonatal lupus is a not so common autoimmune disease. It is not true lupus as all the symptoms will completely disappear after 6 months of age. Neonatal lupus is also known by several other terms. The condition is also called as:...

• Muscular Dystrophy: Telling a Child the Truth About His/Her Condition

  Muscular dystrophy is a category of muscle diseases that cause progressive weakness and loss of muscle mass.  Muscular dystrophy (MD) is either inherited or can be due to a genetic mutation. Kids with MD usually follow a normal pattern of growth development in the first few years of their lives,...